Published by Josh White on 3rd May 2022
(Sharecast News) - Aquaculture biotechnology company Benchmark has been granted a variation to its marketing authorisation for 'Ectosan Vet' from the Norwegian Medicines Agency, it announced on Tuesday.
URL: http://www.digitallook.com/dl/news/story/32646272/...